Skip to main content
SpringerLink
Log in

Experimental determination of multiple thermodynamic and kinetic risk factors for nephrolithiasis in the urine of healthy controls and calcium oxalate stone formers: does a universal discriminator exist?

  • Original Paper
  • Published:
Urolithiasis Aims and scope Submit manuscript

Abstract

Nephrolithiasis is thought to be governed by urinary thermodynamic and kinetic risk factors. However, identification of one or more of these factors which consistently and unambiguously differentiates between healthy subjects (N) and calcium oxalate (CaOx) renal stone patients (SF) remains elusive. The present study addresses this challenge. 24 h urines were collected from 15 N and 10 SF. Urine compositions were used to compute thermodynamic risk indices including urinary ratios, quotients and supersaturation (SS) values, while CaOx metastable limits (MSL) were determined experimentally. Crystallisation kinetics was determined by measuring rates of particle formation (number, volume, size) using a Coulter counter multisizer (CC) and a Coulter flow cytometer (FC). Particle shapes were qualitatively differentiated by FC and were viewed directly by scanning electron microscopy. Several urinary composition ratios and risk quotients were significantly different between the groups. However, there were no significant differences between CaOx MSL or SS values. Using transformed FC data, the rate of CaOx crystallisation in SF was significantly greater than in N. This was not supported by CC measurements. There were no significant differences between the groups with respect to particle size or CaOx crystal growth rates. Single and aggregated CaOx dihydrate crystals were observed in both groups with equal frequency and there were no differences in the kinetic properties of these deposits. A few CaOx monohydrate crystals were observed in SF. Although several risk factors were found to be significantly different between the groups, none of them were consistently robust when compared to other cognate factors. Arguments were readily invoked which demonstrated inter-factor inconsistencies and conflicts. We suspect that a unique discriminatory factor, such as any of those which we investigated in the present study, may not exist.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Robertson WG, Peacock M (1983) Review of risk factors in calcium oxalate urolithiasis. World J Urol 1:114–118

    Article  Google Scholar 

  2. Tiselius HG (1997) Risk formulas in calcium oxalate urolithiasis. World J Urol 15:176–185

    Article  CAS  PubMed  Google Scholar 

  3. Laube N, Kleinen L (2011) Risk indices. In: Rao PN, Preminger GM, Kavanagh JP (eds) Urinary tract stone disease. Springer-Verlag Limited, London, pp 355–368

    Google Scholar 

  4. Hess B, Kok DJ (1996) Nucleation, growth, and aggregation of stone-forming crystals. In: Coe FL, Favus MJ, Pak CYC, Parks JH, Preminger GM (eds) Kidney stones: medical and surgical management. Lippincott-Raven Publishers, Philadelphia, pp 3–32

    Google Scholar 

  5. Chiriboga J (1963) Some properties of an oxalic oxidase purified from barley seedlings. Biochem Biophys Res Commun 11:277–282

    Article  CAS  Google Scholar 

  6. Gruber W, Mollering H (1966) Citrat-lyase und bestimmung von citrate. Biochemische Zeitschrift 346:85–88

    CAS  Google Scholar 

  7. May PM, Murray K (1991) JESS, a joint expert speciation system—1. Talanta 38:1409–1417

    Article  CAS  PubMed  Google Scholar 

  8. Ryall RL, Hibberd CM, Marshall VR (1985) A method for measuring inhibitory activity in whole urine. Urol Res 3:285–289

    Google Scholar 

  9. Markovic M, Komunjer L (1979) A new method to follow crystal growth by coulter counter. J Cryst Growth 46:701–705

    Article  CAS  Google Scholar 

  10. Rodgers A, Hibbert B, Probyn T (1995) Determination of urinary calcium oxalate crystallisation mechanisms and kinetics using flow cytometry. Urol Int 55(2):93–100

    Article  CAS  PubMed  Google Scholar 

  11. Bewick V, Cheek L, Ball J (2005) Statistics review 14: logistic regression. Crit Care 9(1):112–118

    Article  PubMed Central  PubMed  Google Scholar 

  12. Tiselius HG (1982) An improved method for the routine biochemical evaluation of patients with recurrent calcium oxalate stone disease. Clin Chim Acta 122(3):409–418

    Article  CAS  PubMed  Google Scholar 

  13. Tiselius HG (1983) Different estimates of the risk of calcium oxalate crystallization in urine. Eur Urol 9:231–234

    CAS  PubMed  Google Scholar 

  14. Tiselius HG (1984) A simplified estimate of ion-activity product of calcium phosphate in urine. Eur Urol 10:191–195

    CAS  PubMed  Google Scholar 

  15. Parks JH, Coe FL (1986) A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int 30:85–90

    Article  CAS  PubMed  Google Scholar 

  16. Tiselius HG (1989) Standardized estimate of the ion activity product of calcium oxalate in urine from renal stone formers. Eur Urol 16:48–50

    CAS  PubMed  Google Scholar 

  17. Tiselius HG (1991) Aspects on estimation of the risk of calcium oxalate crystallization in urine. Urol Int 47:255–259

    Article  CAS  PubMed  Google Scholar 

  18. Esen T, Akinci M, Tellaloglu S (1994) Stone formation risk index (SFRI): a possible prognostic factor governing the need for metaphylaxy. In: Ryall RL, Bais R, Marshall VR, Rofe AM, Smith LH, Walker VR (eds) Urolithiasis 2 Proceedings 7th International Symposium on Urolithiasis. New York: Plenum Press, pp 410

  19. Daudon M, Labrunie M, Ivaldi A, et al (1996) A new crystallization risk index (CRI) for calcium oxalate (CaOx) stone formers. In: Pak CYC, Resnick MI, Preminger GM (eds) Urolithiasis 1996: Proceedings of the 8th International Symposium on Urolithiasis. Dallas: Millet the Printer Inc, pp 357–358

  20. Porile JL, Asplin JR, Parks JH et al (1996) Normal calcium oxalate crystal growth inhibition in severe calcium oxalate nephrolithiasis. J Am Soc Nephrol 7(4):602–607

    CAS  PubMed  Google Scholar 

  21. McConnell N, Campbell S, Gillanders I et al (2002) Risk factors for developing renal stones in inflammatory bowel disease. BJU Int 89(9):835–841

    Article  CAS  PubMed  Google Scholar 

  22. Robertson WG, Hughes H (1993) Importance of mild hyperoxaluria in the pathogeness of urolithiasis—new evidence from studies in the Arabian peninsula. Scanning Micros 7:391–401

    CAS  Google Scholar 

  23. Rodgers AL (2014) Urinary saturation: casual or causal risk factor in urolithiasis? BJU Int 114(1):104–110

    Article  PubMed  Google Scholar 

  24. Cirillo M, Laurenzi M, Panarelli W, Stamler J (1994) Urinary sodium to potassium ratio and urinary stone disease. The Gubbio Population Study Research Group. Kidney Int 46(4):1133–1139

    Article  CAS  PubMed  Google Scholar 

  25. Tiselius HG (2011) A hypothesis of calcium stone formation: an interpretation of stone research during the past decades. Urol Res 39:231–243

    Article  PubMed  Google Scholar 

  26. Kok DJ, Khan SR (1994) Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46:847–854

    Article  CAS  PubMed  Google Scholar 

  27. Kavanagh JP (1992) Methods for the study of calcium oxalate crystallization and their application to urolithiasis research. Scanning Micros 6:685–705

    CAS  Google Scholar 

  28. Ryall RL, Chauvet MC, Grover PK (2001) A space oddity. In: Kok DJ, Romijn HC, Verhagen P, Verkoelen CF (eds) Eurolithiasis 9th European Symposium on Urolithiasis. Shaker Publishing, Maastricht, pp 273–274

    Google Scholar 

  29. Wesson J, Worcester E, Weissner J et al (1998) Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules. Kidney Int 33:952–957

    Article  Google Scholar 

  30. Ryall RL (2011) The possible roles of inhibitors, promoters and macromolecules in the formation of calcium kidney stones. In: Preminger GM, Kavanagh JP (eds) Rao NP. Urinary Tract Stone Disease, London, pp 31–60

    Google Scholar 

  31. Daudon M, Bazin D, Letavernier E (2015) Randall’s plaque as the origin of calcium oxalate kidney stones. Urolithiasis 43(suppl 1):S5–S11

    Article  Google Scholar 

Download references

Acknowledgments

The authors wish to thank the South African National Research Foundation, the South African Medical Research Council and the University of Cape Town for financial support.

Conflict of interest

The authors declare that there are no conflicts of interest.

Author information

Authors and Affiliations

  1. Department of Chemistry, University of Cape Town, Rondebosch, Cape Town, 7701, South Africa

    A. L. Rodgers, D. Webber & B. Hibberd

Authors
  1. A. L. Rodgers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Webber
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Hibberd
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. L. Rodgers.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rodgers, A.L., Webber, D. & Hibberd, B. Experimental determination of multiple thermodynamic and kinetic risk factors for nephrolithiasis in the urine of healthy controls and calcium oxalate stone formers: does a universal discriminator exist?. Urolithiasis 43, 479–487 (2015). https://doi.org/10.1007/s00240-015-0802-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-015-0802-4

Keywords

Search

Navigation